2015
DOI: 10.1111/ene.12878
|View full text |Cite
|
Sign up to set email alerts
|

Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts

Abstract: Different patterns of change amongst QEEG measures across LTS and PD cognitive states suggest that they correlate with heterogeneous pathophysiologies of cortical dysfunction within the PD clinical spectrum. In addition, the biomarker application of a specific spectral QEEG measure needs to be selectively suited to its study purpose.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
45
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(49 citation statements)
references
References 18 publications
3
45
0
1
Order By: Relevance
“… 16 22–24 Similarly, patients with Parkinson's disease and cognitive decline have increased θ and decreased α power and significantly lower median frequency compared to healthy controls. 25 26 When subdividing the patient group, we found lower background frequency, α power and α/θ power ratio in patients with sCJD when compared to the IPD group, in parallel to differences in the MRC Scale scores. Asymptomatic carriers of prion protein gene mutation did not show any EEG abnormalities.…”
Section: Discussionmentioning
confidence: 73%
“… 16 22–24 Similarly, patients with Parkinson's disease and cognitive decline have increased θ and decreased α power and significantly lower median frequency compared to healthy controls. 25 26 When subdividing the patient group, we found lower background frequency, α power and α/θ power ratio in patients with sCJD when compared to the IPD group, in parallel to differences in the MRC Scale scores. Asymptomatic carriers of prion protein gene mutation did not show any EEG abnormalities.…”
Section: Discussionmentioning
confidence: 73%
“…Though remarkably similar to those measured during speech perception ( Saltuklaroglu et al, 2017 ) and resting state ( Joos et al, 2014 ), reduced μ-β spectral power in the right hemisphere in PWS in the current study did not reach statistical significance. Group spectral differences may be important as they distinguish healthy controls from clinical populations such as individuals with dyslexia ( Galin et al, 1992 ; Papagiannopoulou and Lagopoulos, 2016 ), insomnia ( Buysse et al, 2008 ), epilepsy ( Adebimpe et al, 2015 ), and Parkinson's ( Caviness et al, 2016 ). Thus, further examination is warranted in an attempt to identify a neural biomarker for stuttering.…”
Section: Discussionmentioning
confidence: 99%
“…EEG spectral differences have been used to differentiate matched controls from those with pathological conditions like dyslexia (Galin et al, 1992;Papagiannopoulou and Lagopoulos, 2016), insomnia (Buysse et al, 2008), fibromyalgia (Gonzalez-Roldan et al, 2016), epilepsy (Adebimpe et al, 2015), adolescents with sports related concussions (Balkan et al, 2015), and Parkinson’s disease (Caviness et al, 2016). In the current study, μ-β amplitudes did not correlate with a behavioral measure of stuttering severity making it unclear how well μ-β amplitude defines the disorder.…”
Section: Discussionmentioning
confidence: 99%